Download PDF
Planta Med 2011; 77(16): 1794-1799
DOI: 10.1055/s-0030-1271120
Pharmacokinetic Investigations
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Absolute/Relative Bioavailability and Metabolism of Dodeca-2E,4E,8Z,10E/Z-Tetraenoic Acid Isobutylamides (Tetraenes) after Intravenous and Oral Single Doses to Rats

Karin Ardjomand-Woelkart1 , 5 , Manfred Kollroser2 , Christoph Magnes3 , Frank Sinner3 , Reginald F. Frye4 , Hartmut Derendorf1 , Rudolf Bauer5 , Veronika Butterweck1
  • 1Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA
  • 2Institute of Forensic Medicine, Medical University of Graz, Graz, Austria
  • 3Joanneum Research, Institute of Medical Technologies and Health Management, Graz, Austria
  • 4Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida, USA
  • 5Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Karl-Franzens-University Graz, Graz, Austria
Further Information

Publication History

received February 12, 2011 revised April 17, 2011

accepted April 26, 2011

Publication Date:
20 May 2011 (online)

    Permissions and Reprints

Abstract

The present study assessed the absolute and relative bioavailabilities of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (tetraenes), the main bioactive constituents in Echinacea, administered as pure compounds or in the form of an Echinacea purpurea root extract preparation. Tetraenes were administered orally by gavage or intravenously in a dose of 0.75 mg/kg. The extract was administered orally in a dose of 158.6 mg/kg which corresponds to the same amount of tetraenes. Pharmacokinetic parameters of tetraenes were calculated by non-compartmental analysis using WinNonlin® 5.2 software. Mean dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamide dose-normalized plasma area under the concentration-time curve (AUC0–∞/dose) was 3.24 ± 0.32 min · ng/mL/µg and 0.95 ± 0.16 min · ng/mL/µg after iv and oral administrations, respectively, and 1.53 ± 0.18 min · ng/mL/µg after oral administration of the Echinacea root extract. The absolute oral bioavailability of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides was 29.2 ± 2.3 %, which was increased to 47.1 ± 7.2 % (1.6-fold) by administration of the Echinacea extract. Administration of an Echinacea extract increased blood exposure with no impact on Cmax, but prolonged the elimination half-life to 123.3 ± 15.7 min in comparison to 35.8 ± 6.5 min after administration of the pure dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides.

Key words

Echinacea - Asteraceae - dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides - absolute bioavailability - relative bioavailability - LC-MS

References

  • 1 Bauer R. Chemistry, analysis and immunological investigations of Echinacea phytopharmaceuticals. In: Wagner H, editor Immunomodulatory agents from plants. Basel, Boston, Berlin: Birkhäuser Verlag; 1999: 41-88
    Google Scholar
  • 2 Woelkart K, Xu W, Pei Y, Makriyannis A, Picone R P, Bauer R. The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots.  Planta Med. 2005;  71 701-705
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Woelkart K, Bauer R. The role of alkamides as an active principle of Echinacea.  Planta Med. 2007;  73 615-623
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Woelkart K, Salo-Ahen O H M, Bauer R. CB receptor ligands from plants.  Curr Top Med Chem. 2008;  8 173-186
    CrossrefPubMedGoogle Scholar
  • 5 Gertsch J, Schoop R, Kuenzle U, Suter A. Echinacea alkylamides modulate TNF-α gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways.  FEBS Lett. 2004;  577 563-569
    CrossrefPubMedGoogle Scholar
  • 6 Burger R A, Torres A R, Warren R P, Caldwell V D, Hughes B D. Echinacea-induced cytokine production by human macrophages.  Int J Immunopharmacol. 1997;  19 371-379
    CrossrefPubMedGoogle Scholar
  • 7 Goel V, Chang C, Slama J V, Barton R, Bauer R, Gahler R. Echinacea stimulates macrophage function in the lung and spleen of normal rats.  J Nutr Biochem. 2002;  13 487-492
    CrossrefPubMedGoogle Scholar
  • 8 Rininger J A, Kickner S, Chigurupati P, McLean A, Franck Z. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood cells.  J Leukoc Biol. 2000;  68 503-510
    PubMedGoogle Scholar
  • 9 Matthias A, Banbury L, Stevenson L M, Bone K M, Leach D N, Lehmann R P. Alkylamides from Echinacea modulate induced immune responses in macrophages.  Immunol Invest. 2007;  36 117-130
    CrossrefPubMedGoogle Scholar
  • 10 Matthias A, Blanchfield J T, Penman K G, Toth I, Lang C S, De Voss J J, Lehmann R P. Permeability studies of alkylamides and caffeic acid conjugates from Echinacea using a Caco-2 cell monolayer model.  J Clin Pharm Ther. 2004;  29 7-13
    CrossrefPubMedGoogle Scholar
  • 11 Woelkart K, Koidl C, Grisold A, Gangemi J D, Turner R B, Marth E, Bauer R. Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans.  J Clin Pharmacol. 2005;  45 683-689
    CrossrefPubMedGoogle Scholar
  • 12 Woelkart K, Marth E, Raggam R, Suter A, Schoop R, Koidl C, Kleinhappl B, Bauer R. Bioavailability and pharmacokinetic studies on Echinacea purpurea preparations and their interaction with the immune system.  Int J Clin Pharmacol Ther. 2006;  44 401-408
    CrossrefPubMedGoogle Scholar
  • 13 Woelkart K, Dittrich P, Beubler E, Pinl F, Schoop R, Suter A, Bauer R. Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans.  Planta Med. 2008;  74 651-656
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Matthias A, Addison R S, Agnew L L, Bone K M, Watson K, Lehmann R P. Comparison of Echinacea alkylamide pharmacokinetics between liquid and tablet preparations.  Phytomedicine. 2007;  14 587-590
    CrossrefPubMedGoogle Scholar
  • 15 Matthias A, Gillam E M J, Penman K G, Matovic N J, Bone K M, De Voss J J, Lehmann R P. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes.  Chem Biol Interact. 2005;  155 62-70
    CrossrefPubMedGoogle Scholar
  • 16 Xing J, Xie C F, Lou H X. Recent applications of liquid chromatography-mass spectrometry in natural products bioanalysis.  J Pharm Biomed. 2007;  44 368-378
    CrossrefPubMedGoogle Scholar
  • 17 ESCOP Monographs. The Scientific Foundation for Herbal Medicinal Products. Stuttgart, New York: Thieme Verlag; 2003
    Google Scholar
  • 18 Monograph of the German Commission E, B. Anz. No. 162 from 29.08.1992. Köln: Bundesanzeiger Verlagsgesellschaft; 1992
    Google Scholar
  • 19 Rucker R B. Allometric scaling, metabolic body size and interspecies comparisons of basal nutritional requirements.  J Anim Physiol Anim Nutr. 2007;  91 148-156
    CrossrefPubMedGoogle Scholar
  • 20 Zeller W, Weber H, Panoussis B, Bürge T, Bergmann R. Refinement of blood sampling from the sublingual vein of rats.  Lab Anim UK. 1998;  32 369-376
    PubMedGoogle Scholar
  • 21 Woelkart K, Frye R F, Bauer R, Derendorf H, Butterweck V. Pharmacokinetics and tissue distribution of dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after oral administration in rats.  Planta Med. 2009;  75 1306-1313
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Bu W, Myers N, McCarty J D, O'Neill T, Hollar S, Stetson P L, Sved D W. Simultaneous determination of six urinary porphyrins using liquid chromatograph-tandem mass spectrometry.  J Chromatogr B Anal Technol Biomed Life Sci. 2003;  783 411-423
    CrossrefPubMedGoogle Scholar
  • 23 Schilcher H. Standardisierung, Kontrolle und Qualitätsprüfung von nichttoxischen flüssigen Arzneipflanzenzubereitungen.  Arzneimittelstandardisierung. 1965;  6 649-655
    PubMedGoogle Scholar
  • 24 Menßen H G. Standardisierte Arzneien aus Heilpflanzen und ihre Bedeutung für die moderne Phytotherapie.  Therapiewoche. 1968;  18 1432-1433
    PubMedGoogle Scholar
  • 25 Eder M, Mehnert W. Pflanzliche Begleitstoffe – wertvolle Hilfsstoffe oder überflüssiger Ballast?.  Pharm unserer Zeit. 2000;  29 377-384
    CrossrefPubMedGoogle Scholar
  • 26 Yata N N, Sugihara R, Yamajo T, Murakami Y, Higashi H, Kimata K, Nakayama T, Kuzuki T, Tanaka O. Enhanced small intestinal absorption of beta-lactam antibiotics in rats in the presence of monodesmosides from pericarps of Sapindus mukurossi (Ennmei-hi).  J Pharmacobiodyn. 1986;  9 211-217
    CrossrefPubMedGoogle Scholar
  • 27 Hänsel R, Sticher O, Steinegger E. Pharmakognosie – Phytopharmazie. Berlin, Heidelberg: Springer-Verlag; 1999
    Google Scholar
  • 28 Keledjian J, Duffield P H, Janieson D D, Lidgard R O, Duffield A M. Uptake into mouse brain of four compounds present in the psychoactive beverage Kava.  J Pharm Sci. 1988;  77 1003-1006
    CrossrefPubMedGoogle Scholar
  • 29 Biber A, Nöldner M, Schlegelmilch R. Development of a formulation of Kava-Kava extract through pharmacokinetic experiments in animals.  Naunyn Schmiedebergs Arch Pharmacol. 1992;  345 R24
    PubMedGoogle Scholar
  • 30 Vinson J A, Bose P. Comparative bioavailability to humans of ascorbic acid alone or in a citrus extract.  Am J Clin Nutr. 1988;  48 601-604
    PubMedGoogle Scholar
  • 31 List P H, Schmid W, Weil E. Reinsubstanz oder galenische Zubereitung.  Drug Res. 1969;  19 181-185
    PubMedGoogle Scholar
  • 32 Butterweck V. Mechanism of action of St. John's wort in depression: what is known?.  CNS Drugs. 2003;  17 539-562
    CrossrefPubMedGoogle Scholar
  • 33 Butterweck V, Christoffel V, Nahrstedt A, Petereit F, Spengler B, Winterhoff H. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.  Life Sci. 2003;  73 627-639
    CrossrefPubMedGoogle Scholar
  • 34 Butterweck V, Petereit F, Winterhoff H, Nahrstedt A. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test.  Planta Med. 1998;  64 291-294
    Article in Thieme ConnectPubMedGoogle Scholar

Dr. Veronika Butterweck, Associate Professor of Pharmaceutics

Department of Pharmaceutics, College of Pharmacy
University of Florida

1600 SW Archer Road

Gainesville, Florida 32610

USA

Phone: +1 35 22 73 78 59

Fax: +1 35 22 73 78 54

Email: butterwk@cop.ufl.edu

      >